Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction?: Results of one-year serial echocardiographic follow-up from the captopril and thrombolysis study (CATS)

Journal of the American College of Cardiology

Volumn 28, Issue 1, 1996, Pages 114-121

  Van Gilst, Wiek H ^a,b,c   Kingma, J Herre ^a,c   Peels, Kathinka H ^a,d   Dambrink, Jan Henk E ^a,c   Sutton, Martin St John ^a,e  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

^d CATHARINA HOSPITAL   (Netherlands)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYBUTYRATE DEHYDROGENASE; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOLYTIC AGENT; NITRIC ACID DERIVATIVE; PLACEBO; STREPTOKINASE;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART DILATATION; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE VOLUME; HEART REINFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0030198596     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(96)00113-1     Document Type: Article

References (22)

1. 1. Hammermeister KE, DeRouen TA, Dodge HT, Variables predictive of survival in patients with coronary artery disease: selection by univariate and multivariate analysis from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation 1979;59: 421-30.
2. 2. White HD, Norris RM, Brown MA, Brandt PWT, Whitlock RML, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
3. 3. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990; 81:1161-72.
4. 4. Third International Study of Infarct Survival Collaborative Group. ISIS-3: a randomized comparison of streptokinase vs. tissue plasminogen activator vs. anistreplase and of aspirin plus heparin vs. aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992;339:753-70.
5. 5. Warren SE, Royal HD, Markis JE, Grossman W, McKay RG. Time course of left ventricular dilation after myocardial infarction: influence of infarctrelated artery and success of coronary thrombolysis. J Am Coll Cardiol 1988;11:12-9.
6. 6. Gruppo Italiano per lo Studio della Streptochinasi nelTInfarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
7. 7. Second International Study of Infarct Survival Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-60.
8. 8. Pfeffer MA, Braunwald E, Moyé LA, et al. Effect of captopril administration on infarct expansion, left ventricular remodeling and exercise capacity after acute myocardial infarction. Am J Cardiol 1991;68:713-8.
9. 9. Oldroyd KG, Pye MP, Ray SG. Effects of early captopril administration on infarct expansion, left ventricular remodeling and exercise capacity after acute myocardial infarction. Am J Cardiol 1991;68:713-8.
10. 10. Fourth International Study of Infarct Survival Collaborative Group. Fourth International Study of Infarct Survival: a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-85.
11. 11. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-3 (GISSI). GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115-22.
12. 12. Acute Infarction Ramipril Efficacy (AIRE) study investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-8.
13. 13. Kingma JH, van Gilst WH, Peels KH, Dambrink JHE, Verbeugt FWA, Wielinga RP. Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction. Results from the Captopril and Thrombolysis Study (CATS). Eur Heart J 1994;15:898-907.
14. 14. van der Laarse A, Kerkhof PLM, Vermeer F, et al. Relation between infarct size and left ventricular performance assessed in patients with first acute myocardial infarction randomized to intracoronary thrombolytic therapy or to conventional treatment. Am J Cardiol 1988;61:1-7.
15. 15. Goldstein H. Efficient statistical modeling of longitudinal data. Ann Human Biol 1986;13:129-41.
16. 16. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 1985;72:406-12.
17. 17. Sharpe N, Smith H, Murphy J, Greaves S, Hart H, Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting enzyme inhibition. Lancet 1991;337:1174.
18. 18. St. John Sutton M, Pfeffer MA, Plappert T, et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 1994;89:68-75.
19. 19. van Gilst WH, de Graeff PA, Kingma JH, Wesseling H, de Langen CDJ. Captopril reduces purine loss and reperfusion arrhythmias in the rat heart after coronary artery occlusion. Eur J Phannacol 1984;100:113-7.
20. 20. de Graeff PA, van Gilst WH, de Langen CDJ, Wesseling H. Effects of captopril in a closed-chest pig model against ischemia-reperfusion injury. Naun Schmied Arch Pharmacol 1986;280:181-93.
21. 21. Studies of Left Ventricular Dysfunction Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
22. 22. Swedberg K, Kjekshus J, Rasmussen K, Ryden L, Wedel H, CONSENSUS II study group. Effects of early administration of enalapril on mortality in patients with acute myocardial infarction. N Engl J Med 1992;327:678-84.